Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
Alexander M.M. Eggermont(Erasmus MC), Stefan Suciu(European Organisation for Research and Treatment of Cancer), Mario Santinami(Fondazione IRCCS Istituto Nazionale dei Tumori), Alessandro Testori(European Institute of Oncology), Wim H.J. Kruit(Erasmus MC), Jeremy Marsden(NIHR Surgical Reconstruction and Microbiology Research Centre), Cornelis J.A. Punt(Radboud University Medical Center), François Salès(Institut Jules Bordet), Martin Gore(Royal Marsden Hospital), Rona M. MacKie(University of Glasgow), Zvonko Kusić(Sisters of Charity Hospital), Reinhard Dummer, Axel Hauschild(Kiel University), E. Musat(European Organisation for Research and Treatment of Cancer), Alan Spatz(Institut Gustave Roussy), Ulrich Keilholz(Charité - Universitätsmedizin Berlin)
Cited by 642
Abstract
Related Papers
No related papers found
Powered by citation graph analysis